These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 7515266)

  • 1. Collagenase activity and collagenase-inhibitory factors of serum and bone marrow fibroblast-conditioned medium in chronic myelogenous leukaemia.
    Yonekura S; Nagao T
    Br J Haematol; 1994 Feb; 86(2):308-15. PubMed ID: 7515266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
    Ries C; Loher F; Zang C; Ismair MG; Petrides PE
    Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Overexpression of Shp-2 is associated with the unlimited growth and apoptosis resistance of p210 bcr-abl-mediated chronic myeloid leukemia].
    Zhu XZ; Yu YZ; Fang YM; Liang Y; Lü QH; Xu RZ
    Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1903-6. PubMed ID: 16255985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow fibroblasts-conditioned medium regulates the proliferation of leukemic cells.
    Kubota T; Nagao T; Arimori S
    Tokai J Exp Clin Med; 1988 Feb; 13(1):45-51. PubMed ID: 3232161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased growth and collagen synthesis of bone marrow fibroblasts from patients with chronic myelocytic leukaemia.
    Yonekura S; Nagao T; Arimori S
    Br J Haematol; 1985 Sep; 61(1):93-9. PubMed ID: 3863668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chemokines in chronic myeloid leukemia].
    Mukaida N; Baba T
    Rinsho Ketsueki; 2016 Feb; 57(2):129-36. PubMed ID: 26935630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Pichert G; Roy DC; Gonin R; Alyea EP; Bélanger R; Gyger M; Perreault C; Bonny Y; Lerra I; Murray C
    J Clin Oncol; 1995 Jul; 13(7):1704-13. PubMed ID: 7602361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bcr-abl-positive cells secrete angiogenic factors including matrix metalloproteinases and stimulate angiogenesis in vivo in Matrigel implants.
    Janowska-Wieczorek A; Majka M; Marquez-Curtis L; Wertheim JA; Turner AR; Ratajczak MZ
    Leukemia; 2002 Jun; 16(6):1160-6. PubMed ID: 12040448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow microenvironment confers imatinib resistance to chronic myelogenous leukemia and oroxylin A reverses the resistance by suppressing Stat3 pathway.
    Li X; Miao H; Zhang Y; Li W; Li Z; Zhou Y; Zhao L; Guo Q
    Arch Toxicol; 2015 Jan; 89(1):121-36. PubMed ID: 24671465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suitability of the PAXgene system to stabilize bone marrow RNA in imatinib-resistant patients with chronic myeloid leukemia.
    Ernst T; Hoffmann J; Erben P; Hehlmann R; Hochhaus A; Müller MC
    Clin Chem Lab Med; 2008; 46(3):318-22. PubMed ID: 18303987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of evidence for abnormal autocrine or paracrine mechanisms underlying the uncontrolled proliferation of primitive chronic myeloid leukemia progenitor cells.
    Otsuka T; Eaves CJ; Humphries RK; Hogge DE; Eaves AC
    Leukemia; 1991 Oct; 5(10):861-8. PubMed ID: 1961020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of multidrug resistance 1 gene in association with CXCL12 in chronic myelogenous leukaemia.
    Onishi I; Nakagawa Y; Murayama T; Hidaka M; Yamamoto K; Abe-Suzuki S; Abe S; Kurata M; Kitagawa M
    Pathology; 2014 Dec; 46(7):623-9. PubMed ID: 25393253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of collagenase by human fibroblasts and bone marrow stromal cells.
    Takahashi GW; Moran D; Andrews DF; Singer JW
    Leukemia; 1994 Feb; 8(2):305-8. PubMed ID: 8309254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histological and In Vivo Microscopic Analysis of the Bone Marrow Microenvironment in a Murine Model of Chronic Myelogenous Leukemia.
    Weissenberger ES; Krause DS
    Methods Mol Biol; 2016; 1465():59-72. PubMed ID: 27581139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic myelogenous leukaemia exosomes modulate bone marrow microenvironment through activation of epidermal growth factor receptor.
    Corrado C; Saieva L; Raimondo S; Santoro A; De Leo G; Alessandro R
    J Cell Mol Med; 2016 Oct; 20(10):1829-39. PubMed ID: 27196940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preleukemic phase of chronic myelogenous leukemia: morphologic and immunohistochemical characterization of 7 cases.
    Aye le L; Loghavi S; Young KH; Siddiqi I; Yin CC; Routbort MJ; Liang M; Eilerman K; Medeiros LJ; Brynes RK; Bueso-Ramos C
    Ann Diagn Pathol; 2016 Apr; 21():53-8. PubMed ID: 27040932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in the bone marrow microenvironment may elicit defective hematopoiesis: a comparison of aplastic anemia, chronic myeloid leukemia, and normal bone marrow.
    Park M; Park CJ; Cho YW; Jang S; Lee JH; Lee JH; Lee KH; Lee YH
    Exp Hematol; 2017 Jan; 45():56-63. PubMed ID: 27693387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of matrix metalloproteinases (MMP-2 and -9) and tissue inhibitors of metalloproteinases (TIMP-1 and -2) in acute myelogenous leukaemia blasts: comparison with normal bone marrow cells.
    Janowska-Wieczorek A; Marquez LA; Matsuzaki A; Hashmi HR; Larratt LM; Boshkov LM; Turner AR; Zhang MC; Edwards DR; Kossakowska AE
    Br J Haematol; 1999 May; 105(2):402-11. PubMed ID: 10233411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficient proliferation and expansion in vitro of two bone marrow cell populations from patients with acute myeloid leukemia in response to hematopoietic cytokines.
    Montesinos JJ; Sánchez-Valle E; Flores-Figueroa E; Martínez-Jaramillo G; Flores-Guzmán P; Miranda-Peralta E; Gutiérrez-Romero M; Mayani H
    Leuk Lymphoma; 2006 Jul; 47(7):1379-86. PubMed ID: 16923572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of marrow iron patterns with disease status of chronic myelogenous leukemia.
    Welborn JL; Lewis JP
    Leuk Lymphoma; 1993 Aug; 10(6):469-75. PubMed ID: 8401182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.